Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Takao Shigenobu"'
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-6 (2024)
Abstract Background Thymic mucosa-associated lymphoid tissue (MALT) lymphoma is rare and is known to be associated with Sjögren’s syndrome (SjS). SjS is rarely accompanied by serositis. Here, we describe the first case of postoperative cardiac tam
Externí odkaz:
https://doaj.org/article/d49e33064fad4f6a90579ece77be5ff6
Autor:
Shigeki Suzuki, Keisuke Asakura, Masayuki Okui, Naoko Izawa, Makoto Sawafuji, Hiroyuki Sakamaki, Takao Shigenobu, Atsushi Tajima, Naoyuki Oka, Kyohei Masai, Kaoru Kaseda, Tomoyuki Hishida, Hiroyuki Yasuda, Koichi Fukunaga, Hisao Asamura
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background The prevalence of salvage surgeries after drug therapy for non-small cell lung cancer (NSCLC) has risen, mainly due to recent progress in molecular-targeted drugs and immune checkpoint inhibitors for NSCLC. While the safety and ef
Externí odkaz:
https://doaj.org/article/bdc68d7712cc488895148fb85f4fe3b2
Autor:
Takao Shigenobu, Takashi Ohtsuka, Ryutaro Hanawa, Hiroyuki Sakamaki, Akira Yoshizu, Atsushi Tajima
Publikováno v:
Annals of Thoracic & Cardiovascular Surgery; 2023, Vol. 29 Issue 6, p279-286, 8p
Autor:
Shigeki Suzuki, Keisuke Asakura, Masayuki Okui, Makoto Sawafuji, Takao Shigenobu, Atsushi Tajima, Kaoru Kaseda, Kyohei Masai, Tomoyuki Hishida, Hisao Asamura
Publikováno v:
General Thoracic and Cardiovascular Surgery. 70:891-899
Advances in drug therapy and radiotherapy for non-small cell lung cancer resulted in an increased number of salvage surgeries for initially unresectable tumors. This study aimed to evaluate the safety and efficacy of salvage surgery for non-small cel
Autor:
Yohei Masugi, Hirokazu Matsushita, Hiroaki Kuroda, Yusuke Takahashi, Takao Shigenobu, Ryutaro Hanawa, Atsushi Tajima
Publikováno v:
Clinical Lung Cancer. 22:e820-e828
Histologic subtyping offers some prognostic value in lung adenocarcinoma. We thus hypothesized that histologic subtypes may be useful for risk stratification of brain metastasis (BM). In this study, we aimed to investigate the impact of histologic su
Autor:
Yuichiro Hayashi, Yae Kanai, Takayuki Abe, Tatsuro Iwasaki, Tomoyasu Nishimura, Takashi Ohtsuka, Hisao Asamura, Takao Shigenobu, Katsura Emoto, Toshiyuki Shima, Masayuki Shimoda
Publikováno v:
Cancer Science
Programmed death‐ligand 1 (PD‐L1) is an immune modulator that promotes immunosuppression by binding to programmed death‐1 of T‐lymphocytes. Although tumor cell PD‐L1 expression has been shown to be associated with the clinical response to a
Autor:
Atsushi Tajima, Shigeki Suzuki, Akio Kazama, Hiroyuki Sakamaki, Yohei Masugi, Takao Shigenobu
Background. A parenchymal surgical margin of“the clinical tumor size or more” or “2.0 cm or more” has been widely recognized as the optimal margin distance to avoid locoregional recurrence after sublobar resection for non-small cell lung canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7612c6b8680cccb013d6727f9e4ca5aa
https://doi.org/10.21203/rs.3.rs-666274/v1
https://doi.org/10.21203/rs.3.rs-666274/v1
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 33:578-586
Publikováno v:
Transplant Immunology. 53:21-27
Bronchiolitis obliterans (BO), which begins with lymphocytic bronchiolitis (LB), is the most serious manifestations of chronic rejection following lung transplantation. We have evaluated the effects of intraperitoneal administration of pioglitazone,
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:S251
Purpose Bronchiolitis obliterans (BO) and bronchiolitis obliterans syndrome were recognized as serious complications after lung transplantation. We hypothesized that pioglitazone, a peroxisome proliferator-activated receptor (PPAR)-γ agonist, could